Top Medical News

Ibrutinib Plus Prednisone Does Not Improve Response Rates in cGVHD

February 2nd 2023

First-line ibrutinib plus prednisone missed the primary endpoint in the phase 3 iNTEGRATE trial by not improving the response rate in patients with chronic graft-versus-host-disease compared with placebo plus prednisone.

Real-World Data Confirm Ide-cel Safety and Efficacy for Patients With Multiple Myeloma

February 2nd 2023

Although most patients in the real-world setting would not have met the clinical trial eligibility criteria, the efficacy and safety outcomes with idecabtagene vicleucel were similar for both sets of patients with multiple myeloma.

Oncology Nursing News Top Stories: January 2023

February 1st 2023

Each month, Oncology Nursing News® takes a look back at our most popular stories.

ASH Data Offer Treatment Direction for Oncology Nursing Professionals

February 1st 2023

Nilesh Kalariya, PhD, AGPCNP-BC, AOCNP; and Laura J. Zitella, MS, RN, ACNP-BC, AOCN, discuss practice-changing presentations from the 64th American Society of Hematology Annual Meeting and Exposition.

Neoadjuvant Pembrolizumab Elicits High Response Among dMMR/MSI-H Solid Tumors

January 31st 2023

Neoadjuvant pembrolizumab elicited high clinical activity in patients with mismatch repair deficiency/microsatellite instability high solid tumors and was well tolerated.

Most Recent